Kerry, a world leader in taste and nutrition, has announced a new commercial agreement with Japan-based Kameda Seika to market and distribute the company’s rice-derived postbiotic exclusively in the Americas and Europe across a range of applications. Kameda Seika is a leading global rice cracker company with decades of rice research experience. Kameda has extensively researched rice-based lactobacillus for over 25 years and has accumulated several health claims. Kameda’s postbiotic … [Read more...] about Kerry and Kameda Seika announce new exclusive licensing agreement for Japanese rice-derived postbiotic